Tamgiblimab, CAS 2411914-36-6

Product Description: Tamgiblimab (IBI939) is a fully human monoclonal antibody targeting T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT). Tamgiblimab has anticancer effects[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Y. Cheng, et al. 77P A study to evaluate the safety, tolerability and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC). Immuno-Oncology and Technology. DECEMBER 01, 2022.

CAS Number: 2411914-36-6

Molecular Weight: N/A

Compound Purity: 99.0

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99508-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99508-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated